[Federal Register Volume 60, Number 229 (Wednesday, November 29, 1995)]
[Notices]
[Page 61267]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-29091]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Cancer Institute; Notice of Meeting
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting of the National Cancer Institute Frederick Cancer Research &
Development Center Advisory Committee.
Agenda/Purpose: Discussion of previous site visit report and
response for the AIDS Vaccine program and AIDS projects both under
contract with Science Applications International Corporation, site
visit review of the Macromolecular Structure Laboratory with
Advanced Bioscience Laboratories, Inc.
Committee Name: Frederick Cancer Research & Development Center
Advisory Committee.
Date: December 11-13, 1995.
Time: Open Session, Dec. 11-8:30 a.m.-11:00 a.m.; closed
session, Dec. 11-11 a.m.-Dec. 13.
Place: Frederick Cancer Research and Development Center,
Building 549, Executive Board Room, Frederick, MD 21702.
Contact Person: Cedric W. Long, Ph.D., Frederick Cancer Research
and Development Center, P.O. Box B, Frederick, MD 21702, telephone:
301-496-1108.
The meeting will be closed in accordance with the provisions set
forth in sec. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The reports
and the discussions could reveal confidential trade secrets or
commercial property such as patentable material and personal
information concerning individuals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
(CATALOG OF FEDERAL DOMESTIC ASSISTANCE PROGRAM NUMBERS: 93.393,
Cancer Cause and Prevention Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396.
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93.399, Cancer Control.)
Dated: November 21, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-29091 Filed 11-28-95; 8:45 am]
BILLING CODE 4140-01-M
